MTOR and amyotrophic lateral sclerosis: Although effective in delaying the disease onset and extending the lifespan in different ALS mouse models by regulating the mTOR-independent pathway [80–82], lithium failed to show therapeutic benefits in ALS patients in previous clinical trials [83–87].